AstraZeneca raised its sales and profit outlook for the year thanks to strong demand for its cancer drugs and announced a deal to develop an obesity drug that could be given in tablet form rather than as injections.
由于抗癌藥需求強勁，阿斯利康(AstraZeneca)上調了今年的銷售和利潤預期，并宣布一項協議，將開發一種可以片劑而非注射劑方式給藥的減肥藥。
您已閱讀7%（287字），剩余93%（3542字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。